✦ LIBER ✦

EGFR Mutation Status Predict Survival and Response for Patients with Stage III Squamous-cell Carcinoma of Lung Treated with Chemoradiotherapy

✍ Scribed by G. Zhu; F. Li; H. Bai; X. Li; R. Yu; A. Shi; L. Yin; J. Wang

Book ID: 118456312
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.274

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The prognostic significance of tumor hum

The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy

✍ Ho-Young Yhim; Na-Ri Lee; Eun-Kee Song; Jae-Yong Kwak; Soo Teik Lee; Jong Hun Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 357 KB

## Abstract The prognostic relevance of tumor human papillomavirus (HPV) status in anal squamous cell carcinoma (SCC) had not been previously investigated, although its relevance to cervical, head and neck SCC is known. We retrospectively evaluated outcomes in 47 patients with anal SCC treated with

Survival is better predicted with a new

Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy

✍ Berghmans, T.; Lafitte, J.J.; Thiriaux, J.; VanHoutte, P.; Lecomte, J.; Efremidi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Prognostic value of pretreatment serum c

Prognostic value of pretreatment serum carcinoembryonic antigen and squamous cell carcinoma antigen levels for patients with stage I–III non-small cell lung cancer treated with radiation therapy alone

✍ Yoshihiro Saito; Norio Mitsuhashi; Kazushige Hayakawa; Yuko Nakayama; Tomoko Kaz 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 311 KB

Cell-Cycle Regulators and the Ki-67 Labe

Cell-Cycle Regulators and the Ki-67 Labeling Index Can Predict the Response to Chemoradiotherapy and the Survival of Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus

✍ Hiroya Takeuchi; Soji Ozawa; Nobutoshi Ando; Yuko Kitagawa; Masakazu Ueda; Masak 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 138 KB

The impact of age on toxicity, response

The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel

✍ Thomas A. Hensing; Amy H. Peterman; Michael J. Schell; Ji-Hyun Lee; Mark A. Soci 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## BACKGROUND The optimal treatment strategy for elderly patients with advanced nonsmall cell lung carcinoma has not been defined to date. The authors performed a retrospective analysis of a Phase III trial that treated patients who had Stage IIIB or IV nonsmall cell lung carcinoma wit

Prediction of treatment outcome by cispl

Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT)

✍ Frank J.P. Hoebers; Dick Pluim; Marcel Verheij; Alfons J.M. Balm; Harry Bartelin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 188 KB 👁 1 views

## Abstract The purpose of our study was to test the predictive value of cisplatin‐DNA adduct levels in head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatin‐radiation. Patients with advanced‐stage HNSCC were treated within a randomized trial, investigating the optimal route